Inspire Medical Systems, Inc. (INSP)
Automate Your Wheel Strategy on INSP
With Tiblio's Option Bot, you can configure your own wheel strategy including INSP - and automate your put writes, covered calls, and full wheel strategy. Just connect one of the supported brokerages: tastytrade, Schwab, TradeStation or Tradier and go.
Start Your Free Trial NowKey Metrics & Ratings
- symbol INSP
- Rev/Share 29.1901
- Book/Share 22.9713
- PB 3.4652
- Debt/Equity 0.0488
- CurrentRatio 6.1396
- ROIC 0.0526
- MktCap 2354114280.0
- FreeCF/Share 2.8809
- PFCF 27.6932
- PE 44.2152
- Debt/Assets 0.0412
- DivYield 0
- ROE 0.0787
- Rating B-
- Score 2
- Recommendation Sell
- P/E Score 1
- DCF Score 1
- P/B Score 1
- D/E Score 3
Recent Analyst Ratings
| Type | Ticker | Analyst Firm | Previous Rating | Current Rating | Previous Price Target | Current Price Target | Date |
|---|---|---|---|---|---|---|---|
| Initiation | INSP | Evercore ISI | -- | Outperform | -- | $150 | Sept. 2, 2025 |
| Downgrade | INSP | JP Morgan | Overweight | Neutral | -- | $110 | Aug. 5, 2025 |
| Downgrade | INSP | KeyBanc Capital Markets | Overweight | Sector Weight | -- | -- | Aug. 5, 2025 |
| Downgrade | INSP | Truist | Buy | Hold | -- | $125 | Aug. 5, 2025 |
News
Inspire Medical Systems, Inc. (INSP) Q4 2024 Earnings Call Transcript
Published: February 10, 2025 by: Seeking Alpha
Sentiment: Neutral
Inspire Medical Systems, Inc. (NYSE:INSP ) Q4 2024 Earnings Conference Call February 10, 2025 5:00 PM ET Company Participants Ezgi Yagci - Vice President of Investor Relations Tim Herbert - President & Chief Executive Officer Rick Buchholz - Chief Financial Officer Conference Call Participants Travis Steed - Bank of America Securities Danielle Antalffy - UBS Robbie Marcus - JPMorgan Chris Pasquale - Nephron Research Anthony Petrone - Mizuho Financial Group Richard Newitter - Truist Securities David Rescott - Baird Adam Maeder - Piper Sandler Larry Biegelsen - Wells Fargo Shagun Singh - RBC Capital Markets Brett Fishbin - KeyBanc Capital …
Read More
Inspire Medical's Earnings Surge in Q4
Published: February 10, 2025 by: The Motley Fool
Sentiment: Positive
Inspire Medical Systems (INSP -0.64%), known for its innovative devices that use neurostimulation to treat sleep apnea, announced impressive fourth-quarter results on Feb. 10. Earnings per share (EPS) came in at $1.15, well ahead of the $0.73 consensus estimate.
Read More
Inspire (INSP) Reports Q4 Earnings: What Key Metrics Have to Say
Published: February 10, 2025 by: Zacks Investment Research
Sentiment: Positive
Although the revenue and EPS for Inspire (INSP) give a sense of how its business performed in the quarter ended December 2024, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.
Read More
Inspire Medical Systems, Inc. Announces Fourth Quarter and Full Year 2024 Financial Results and Updates 2025 Outlook
Published: February 10, 2025 by: GlobeNewsWire
Sentiment: Neutral
Inspire Reports Year-over-Year Revenue Growth of 25% and Earnings per Share Growth of 135% for the Fourth Quarter 2024 Inspire Reports Year-over-Year Revenue Growth of 25% and Earnings per Share Growth of 135% for the Fourth Quarter 2024
Read More
About Inspire Medical Systems, Inc. (INSP)
- IPO Date 2018-05-03
- Website https://www.inspiresleep.com
- Industry Medical - Devices
- CEO Timothy P. Herbert
- Employees 1246